Can the Lonvi Biosciences pill really extend human lifespan to 150 years?

According to the article, Lonvi Biosciences claims their grapeseed extract-based pill can help people live past 100 and up to 120 years old, though the company's chief technology officer believes "living to 150 is definitely realistic" in the near future.

How is China's longevity research progressing compared to the West?

The article states that Harvard professor Vadim Gladyshev says Chinese researchers "are rapidly catching up" to the West in longevity science, which was once dominated by "wild claims" that alienated many legitimate scientists.

What are the challenges in translating longevity findings from mice to humans?

The article notes that while the Lonvi Biosciences pill has shown promising results in extending the lifespan of mice, "translating what works for mice to human beings requires long and rigorous testing, and what works for mice often disappoints with people."

Home / Science / Chinese Startups Claim Grapeseed Pill Can Extend Life to 150

Chinese Startups Claim Grapeseed Pill Can Extend Life to 150

10 Nov

•

Summary

Chinese longevity startups aim to extend life expectancy to 150 years
Lonvi Biosciences develops anti-aging pills based on grapeseed extract
Harvard professor says longevity science in China is "rapidly catching up"

Chinese Startups Claim Grapeseed Pill Can Extend Life to 150

As of November 10th, 2025, Chinese longevity startups are making significant strides in the race to extend human lifespan. Lonvi Biosciences, a company based in Shenzhen, has developed anti-aging pills using a compound found in grapeseed extract that they claim can increase the lifespan of mice by over 60%. The company's chief technology officer, Lyu Qinghua, boldly predicts that "in a few years, this will be the reality" for humans, with the potential to eliminate cancer within 5-10 years.

China's enthusiasm for longevity research has surged in recent years, driven by both state investment and growing public interest. Harvard professor Vadim Gladyshev notes that Chinese researchers "are rapidly catching up" to the West in this field, which was once dominated by "wild claims" that alienated many scientists. However, experts caution that translating findings from mice to humans is a significant challenge, and "strong scientific intent does not guarantee uniformly high rigor or translational success."

Despite the skepticism, Chinese companies like Lonvi are forging ahead, banking on the growing demand for life-extending treatments among the country's wealthy. The company's CEO, Yip Tszho, believes their grapeseed-based pills, combined with a healthy lifestyle, can help people live past 100 and up to 120 years old. While immortality may still be out of reach, these Chinese startups are determined to push the boundaries of human longevity.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.